What is the best treatment approach for an adult patient with a non-functional adrenal adenoma with features of myelolipoma that has doubled in size over the past 8 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Growing Adrenal Myelolipoma

For a non-functional adrenal adenoma with myelolipoma features that has doubled in size over 8 years, you should proceed with adrenalectomy given the significant growth rate (>5 mm/year threshold), the need to exclude malignancy in an atypical presentation, and the current size likely exceeding 4 cm. 1

Why Surgery is Indicated in This Case

This case presents an unusual clinical scenario that deviates from typical myelolipoma behavior and warrants surgical intervention for several reasons:

Growth Rate Exceeds Guideline Thresholds

  • Adrenalectomy should be considered for adrenal incidentalomas growing >5 mm/year after repeating functional work-up. 1
  • Doubling in size over 8 years represents substantial growth that exceeds the 3 mm/year threshold where no further follow-up is needed 1
  • A recent study from a tertiary referral center found the mean growth rate of observed myelolipomas was only 0.13 cm/year, making your patient's growth rate highly atypical 2

Atypical Presentation Raises Diagnostic Uncertainty

  • While myelolipomas are definitively benign with no malignant potential when correctly diagnosed 3, significant growth over time is unusual and raises concern about the accuracy of the initial diagnosis 4
  • Very large myelolipomas can be confused with necrotic adrenal carcinomas, necessitating surgical removal for definitive diagnosis 4
  • Surgery plays an important role for lesions that cannot be distinguished reliably from malignancy 5

Size Considerations

  • If the lesion has doubled in size over 8 years, it likely now exceeds 4 cm (the threshold where repeat imaging is recommended even for radiologically benign lesions) 1, 6
  • Patients with non-functional adrenal lesions that are radiologically benign but ≥4 cm should undergo repeat imaging in 6-12 months, and surgery should be considered if growth continues 1

Pre-Operative Requirements

Before proceeding to surgery, you must:

Repeat Functional Work-Up

  • Perform complete hormonal evaluation including screening for pheochromocytoma (plasma metanephrines), Cushing's syndrome (1 mg dexamethasone suppression test or 24-hour urinary free cortisol), and if hypertensive or hypokalemic, primary aldosteronism (plasma aldosterone-renin ratio) 6
  • This is critical because approximately 5% of radiologically benign incidentalomas have subclinical hormone production requiring treatment 6
  • The guideline specifically states to repeat functional work-up before considering adrenalectomy for growing lesions 1

Confirm Imaging Characteristics

  • Verify the lesion still demonstrates macroscopic fat on current imaging (CT showing negative Hounsfield units in fat-containing areas) 3
  • If imaging characteristics have changed or become indeterminate, this further supports surgical intervention 2

Surgical Approach

Laparoscopic Adrenalectomy is Preferred

  • Minimally invasive surgery (laparoscopic or retroperitoneoscopic) should be performed when feasible for benign lesions 7
  • Laparoscopic adrenalectomy for myelolipomas has comparable outcomes and morbidity to other adrenal pathology, even for large lesions 8
  • In a series of 15 laparoscopic adrenalectomies for myelolipomas (mean size 8.4 cm), outcomes were excellent with minimal morbidity 8

Consider Open Approach for Very Large Lesions

  • The European Society of Endocrinology suggests 6 cm as a cutoff for considering open rather than laparoscopic adrenalectomy 1, 7
  • One case report described successful open adrenalectomy for a 21-cm myelolipoma 8

Common Pitfalls to Avoid

  • Do not continue surveillance indefinitely for a growing lesion. While surveillance is safe for stable myelolipomas 2, continued growth mandates intervention 1
  • Do not perform adrenal biopsy. The diagnosis should be made based on imaging characteristics and confirmed at surgery 6
  • Do not assume the lesion is benign based solely on fat content. Atypical growth patterns warrant histologic confirmation 5, 4
  • Do not proceed to surgery without repeating hormonal evaluation. Undiagnosed pheochromocytoma can cause intraoperative hypertensive crisis 6

Expected Benefits of Surgery

Surgery in this case is both diagnostic and therapeutic:

  • Provides definitive histologic diagnosis to exclude malignancy 5
  • Prevents potential complications such as spontaneous rupture and hemorrhage, which can lead to cardiovascular shock 5
  • Addresses any mass effect on adjacent organs if present 2
  • Provides symptom relief if the patient has developed abdominal or flank pain 8, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adrenal Myelolipoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal myelolipoma: To operate or not? A case report and review of the literature.

International journal of surgery case reports, 2014

Guideline

Adrenal Nodules Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Size Threshold for Surgical Removal of Adrenal Adenomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adrenal myelolipoma: operative indications and outcomes.

Journal of laparoendoscopic & advanced surgical techniques. Part A, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.